ENDRA Life Sciences

ENDRA's TAEUS Liver Device Achieves MRI-Level Consistency in MASLD Clinical Study

- ENDRA Life Sciences reported that its TAEUS Liver device achieved an intraclass correlation coefficient of 0.89 with 3.3% standard error of measurement in a clinical study evaluating measurement consistency for metabolic dysfunction-associated steatotic liver disease. - The study involved 14 subjects with independent operators performing 56 unique measurements to assess the device's repeatability and reproducibility in real-world clinical conditions. - The results demonstrate the device's potential to deliver MRI-level liver fat quantification at point of care with significantly lower cost than traditional MRI-PDFF, addressing barriers for over two billion people affected by MASLD. - The performance data contrasts sharply with traditional ultrasound techniques that suffer from high inter-observer variability and subjective interpretations.